Figure 6:
Predicted seasonal seroprevalence and prevalence patters in H. monstrosus for EBOV estimated from model fitting and interpolation. (a) Estimated seroprevalence curves from model fitting and sampling data (black dots) used to predict (b) prevalence over 52 weeks. (c) Estimated seroprevalence curves from interpolation and sampling data (black dots) used to predict (d) prevalence over 52 weeks.